Connect with us

Health

Immunogenicity and Reactogenicity of SARS-CoV-2 Vaccines in Patients With Cancer: The CANVAX Cohort Study – DocWire News

J Clin Oncol. 2021 Nov 9:JCO2101891. doi: 10.1200/JCO.21.01891. Online ahead of print.ABSTRACTPURPOSE: The immunogenicity and…

Published

4 years ago

on

November 9, 2021

By

Noosa Online News Publisher

Article feature image

J Clin Oncol. 2021 Nov 9:JCO2101891. doi: 10.1200/JCO.21.01891. Online ahead of print.
ABSTRACT
PURPOSE: The immunogenicity and reactogenicity of SARS-CoV-2 vaccines in patients with cancer are poorly understood.
METHODS: We performed a prospective cohort…

Click here to view the original article.

Related Topics:Australia Docwirenews.com Featured

Australia discovers new solution to fight chronic middle ear infections – BSA bureau

Pfizer-BioNTech COVID-19 vaccine is associated with lower viral load in breakthrough infections – News-Medical.Net

Continue Reading

Advertisement

Noosa News17 hours ago

Family pleads for help after 17-year-old Pheobe Bishop disappears in Bundaberg before flight

Business18 hours ago

ASX 200 lifts on the RBA’s latest interest rate call

Noosa News20 hours ago

‘They’re not taking the concerns of women seriously’

Business21 hours ago

Dividends from ASX 200 bank shares ‘looking very stretched’: expert

About Us	Contact Us

© 2025 Noosa Online News
Privacy Policy